Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (SVE) Revenue

0 Followers

Statistics Revenue

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Revenue

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. had a revenue of 17.51M in the quarter ending Dec 31, 2025, with 265.47%. This bring the company's revenue in the last twelve months to 42.01M, Increased -21.84%. In the fiscal year ending Dec 31, 2025, Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. had annual revenue of 42.01M with -41.46% growth.

Revenue (ttm)

42.01M

Revenue Growth

-41.46%

P/S Ratio

5.45

Revenue/Employee

zł175,770

Employees

239

Market Cap

zł228.82M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	42.01M	-29.75M	-41.46%
Dec 31, 2024	71.76M	13.15M	+22.44%
Dec 31, 2023	58.61M	8.22M	+16.32%
Dec 31, 2022	50.38M	9.23M	+22.43%
Dec 31, 2021	41.15M	995.00K	+2.48%
Dec 31, 2020	40.16M	1.05M	+2.69%
Dec 31, 2019	39.11M	6.81M	+21.10%
Dec 31, 2018	32.29M	889.00K	+2.83%
Dec 31, 2017	31.40M	―	―